TCL launches new website – Human Touch of Chemistry

Chemistry is going to be a lot more fun, as Tata Chemicals reaches out to Young India, through the launch of an interactive portal for the kids The Human Touch of Chemistry. TCL has launched www.humantouchofchemistry.com at a formal function held at the Marriot, Mumbai to release the Dun & Bradstreet Publication ‘Indian Chemical Industry’. [...]

What’s the carbon footprint of your handwash?

Reproduced from cnet news. Start-up Planet Metrics is developing software that could give consumers a better read on the embedded energy of everyday products. The San Francisco-based company on Tuesday released the beta test version of its hosted application, which it calls Rapid Carbon Modeling. It also said Method, which makes eco-friendly home-cleaning products, is [...]

The Elephant in the Room

Intellectual Asset Management has published the article “The Elephant in the Room” by Opperman, Craig P. The article focuses the skyrocketing cost and bloated patent portfolio of American Corporate, Low quality, Marginal relevance, and the process to overcome the same issue e.g. File far fewer applications, clean out that Junk and changing the culture of [...]

Abbott Loses Drug Patent Suit with Centocor

Cited from NewYork Times. A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs. Abbott’s best-selling drug, Humira, competes with the drug Remicade, an arthritis treatment made by the Centocor unit of Johnson & Johnson. That company [...]

Australia – Innovation Patent

The Australia has a separate Patent protection apart from regular utility Patent termed “Innovation patent”, is a protection option specifically designed to protect inventions that do not meet the inventive threshold required for standard patents. Introduced in 2001 to stimulate innovation among small to medium business and local industry, the innovation patent is a relatively [...]

Monsanto sues DuPont over patent

The data is reproduced from the St. Louis Business Journal. Monsanto Co. has sued DuPont to prevent what it calls “unlawful use” of Monsanto’s herbicide-tolerant technologies in soybeans and corn. DuPont subsidiary, Pioneer Hi-Bred International Inc., recently admitted that its technology “presents unacceptable risks to farmers,” Monsanto said. In an effort to repair these deficiencies, [...]

Searching of European Nanotechnology Patents

EPO (European Patent Office) has taken actions to get to grips with this new technology, the one that has been welcomed most by nanotechnologists, was the introduction of the “Y01N” tags to label nanotechnology in EPO databases with, highly efficient tagging system. The Y01N code is not static, but is constantly updated and improved as [...]

PATExpert – Advanced Patent Document Processing Techniques

PATExpert has developed a multimedia content representation formalism based on Semantic Web principles for selected technology areas and investigated new generation semantic patent processing techniques. Features: ·        Semantic web representation mechanisms for patent material ·        User-oriented patent classification ·        Patent information / and meta-information extraction and (semi-) automatic construction of patent knowledge bases ·        Semantic [...]

Agreement to Simplify International Patent Classification (IPC) System

A committee of international experts meeting at the World Intellectual Property Organization (WIPO) in Geneva from March 16 to 20, 2009 agreed to simplify the structure of the international system for classifying patents.  Reform of the system, known as the International Patent Classification (IPC) system, will ensure more consistent search results and their wider use [...]

US court rules largely for patent office on Glaxo

The article is reproduced from the “Alibaba.com”). WASHINGTON, March 20 – A U.S. appeals court largely overturned on Friday GlaxoSmithKline Plc’s summary judgment win in a fight against new patent office rules. The U.S. Court of Appeals for the Federal Circuit held that three of the rules to which Glaxo and other patent holders had [...]